BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients

Familial Cancer

Volumn 11, Issue 1, 2012, Pages 57-67

  Keshavarzi, Fatemeh ^a   Javadi, Gholam Reza ^b   Zeinali, Sirous ^c,d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Kawsar's Human Genetic Research Center   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; Genetic polymorphisms

Indexed keywords

ADENINE; ARGININE; ASPARAGINE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN; CYSTEINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; ISOLEUCINE; LEUCINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; THYMINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; INTRON; IRAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOP CODON;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; IRAN; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 84858296064     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9477-3     Document Type: Article

References (48)

1. De Silva W, Karunanayake EH, Tennekoon KH (2008) Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals. BMC Cancer 8:214
2. Mousavi SM, Mohagheghi MA, Mousavi-Jerrahi A et al (2008) Outcome of breast cancer in Iran: a study of Tehran Cancer Registry data. Asian Pac J Cancer Prev 9(2):275-278
3. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350:1047-1059
4. Lee SM, Park JH, Park HJ (2008) Breast cancer risks in Korean women. A literature review. Int Nurs Rev 55:355-359
5. Hulka BS, Stark AT (1995) Breast cancer: cause and prevention. Lancet 346:883-887
6. Kelsey JL (1993) Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15:256-263
7. Tischer E, Mitchell R, Hartman T et al (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954
8. Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 85:3044-3048
9. Han W, Kang D, Park I, Kim SW, Bae JY, Chung K, Noh D (2004) Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 10:124-130 (Pubitemid 38114170)
10. Teng L, Zheng Y, Wang H (2008) BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B 9(2):85-89 (Pubitemid 351234292)
11. Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou Ch, Rafailidis PI (2007) The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 9(4):R44
12. Belogianni I, Apessos A, Mihalatos M, Labropoulos S, Petounis A, Gaki V, Keramopoulos A, Pandis N (2004) Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 4:61-70
13. Neuhausen SL (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86:2575-2582
14. Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ (1996) Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 65:273-283
15. Southey M, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MRE, Hopper JL, Venter DJ (1999) BRCA1 mutations and other sequence variants in a population-basedsample of Australian women with breast cancer. Br J Cancer 79:34-39 (Pubitemid 28566923)
16. Claes K, Poppe B, Machackova E, Coene I, Foretova L, De Paepe A, Messiaen L (2003) Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 37:314-320 (Pubitemid 36667570)
17. Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Bremond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Leone M, Chauvin F, Easton DF, Lenoir GM, Lasset C (2005) Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Genes Chromosomes Cancer 43:404-413 (Pubitemid 40946475)
18. Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso A (2005) BRCA1 mutations and polymorphisms in a hospital based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 578(1-2):395-405 (Pubitemid 41395340)
19. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424 (Pubitemid 35453558)
20. Zhi X, Szabo C, Chopin S, Suter N, Wang QS, Ostrander EA, Sinilnikova OM, Lenoir GM, Goldgar D, Shi YR YR (2002) BRCA1, BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat 20(6):474
21. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638-1645 (Pubitemid 41079802)
22. Valarmathi MT, Sawheney M, Deo SSV, Shukla NK, Das SN (2004) Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast-ovarian cancer families. Hum Mutat 23:205-211
23. Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chitamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Golgar DE, Szabo CI (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75-88
24. Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G (2006) BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol 17:34-40
25. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
26. den Dunnen JT, Paalman MH (2004) Standardizing mutation nomenclature: why bother? Hum Mutat 22:181-182
27. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814 (Pubitemid 37442253)
28. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900 (Pubitemid 35012462)
29. Ferrer-Costa C, Gelpi JL, Zamakola L (2005) PMUT: a webbased tool for the annotation of pathological mutations on proteins. Bioinformatics 21:3176-3178 (Pubitemid 41418475)
30. Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D, Ponder BA (1997) Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6:285-289 (Pubitemid 27078085)
31. Majdak EJ, De Bock GH, Brozek I, Perkowska M, Ochman K, Debniak J, Milczek T, Cornelisse CJ, Jassem J, Emerich J, Limon J, Devilee P (2005) Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases-preliminary report. Eur J Cancer 41(1):143-150 (Pubitemid 40029667)
32. Nathanson KN, Wooster R, Webber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7:552-556 (Pubitemid 32448321)
33. Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937-948 (Pubitemid 350165853)
34. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646 (Pubitemid 37310920)
35. Page FL, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, Sarasin A (2000) BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 60:5548-5552
36. Starita LM, Parvin JD (2003) The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr Opin Cell Biol 15(3):345-350 (Pubitemid 36638654)
37. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665-676 (Pubitemid 39215065)
38. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton- Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:456-876
39. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841-850
40. Bishop DT, Hopper JL (1997) AT-tributable risks? Nature Genet 15:226 (Pubitemid 27098713)
41. Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brondum-Nielsen K, Gerdes AM, Moller P, Kristoffersson U, Olsson H, Borg A, Monteiro AN (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10:353-360 (Pubitemid 32166546)
42. Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS (2000) The BRCA1 C-terminal domain: structure and function. Mutat Res 460:319-332 (Pubitemid 30628598)
43. Konstantopoulou I, Kroupis C, Ladopoulou A, Pantazidis A, Boumba D, Lianidou ES, Petersen MB, Florentin L, Chiotellis E, Nounesis G, Efstathiou E, Skarlos D, Tsionou C, Fountzilas G, Yannoukakos D (2000) BRCA1 mutation analysis in breast/ ovarian Cancer families from Greece. Hum Mutat 16:272-273
44. Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, Skolnick MH, Gutin A, Tavtigian SV (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41(7):492-507 (Pubitemid 38932109)
45. Sakayori M, Kawahara M, Shiraishi K, Nomizu T, Shimada A, Kudo T, Abe R, Ohuchi N, Takenoshita S, Kanamaru R, Ishioka C (2003) Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1 and BRCA2 genes in familial breast cancer. J Hum Genet 48(3):130-137 (Pubitemid 36362513)
46. Tworek H, Peng R, Fetzer S, Werness BA, Piver MS, Allen HJ (1999) Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. Genet Cytogenet 112(2): 105-118 (Pubitemid 29322732)
47. Kroiss R, Winkler V, Bikas D, Fleischmann E, Mainau C, Frommlet F, Muhr D, Fuerhauser C, Tea M, Bittner B, Kubista E, Oefner PJ, Bauer P, Wagner TM (2005) Austrian Hereditary Breast and Ovarian Cancer Group: younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers. Hum Mutat 26(6):583-589 (Pubitemid 41780481)
48. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC et al (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8(4):387-391 (Pubitemid 24375606)